Oral glucocorticoids (GCs) are frequently used in the treatment of inflammatory conditions,
such as rheumatoid arthritis or asthma. They have adverse skeletal effects, primarily through …

Abstract Glucocorticoid-(GC-) induced osteoporosis and an increased risk of fractures are
one of the most serious problems for patient using long-term GC therapy, such as those with …

Oral glucocorticoids (GCs) are widely used and despite their adverse effects on bone
mineral density, the risk of sustaining osteoporotic fractures is not well addressed. The …

Glucocorticoid (GC) exposure is the most common etiology of drug-induced (secondary)
osteoporosis. Twenty percent of all cases of osteoporosis have been attributed to GC …

Glucocorticoids are widely used to suppress inflammation or the immune system. High
doses and long-term use of glucocorticoids lead to an important and common iatrogenic …

Glucocorticoid drugs interact with bone metabolism at many levels, but their principal action
is to reduce osteoblast number and bone matrix synthesis. Virtually all patients receiving …

Key Clinical Points Glucocorticoid-Induced Osteoporosis Risk factors for glucocorticoid-
induced fractures include age (> 55 years), female sex, white race, and long-term use of …

Glucocorticoid‐induced osteoporosis (GIO) is the second most common form of osteoporosis
and is the most common iatrogenic form of the disease. Fractures may occur in 30% to 50 …

Therapeutic use of glucocorticoids can lead to many well-known adverse events [1]. Of all
potential serious side effects, glucocorticoid-induced osteoporosis (GIOP) is one of the most …

Abstract Treatment with oral corticosteroids is known to decrease bone density but there are
few data on the attendant risk of fracture and on the reversibility of this risk after cessation of …